RxDoctor Payments Data

William Jackson, MD

Family Medicine · Detroit, MINPI 1932236262

Payments from drug & device makers

$1,691in general payments, 2019–2025

Across 16 payments — averaging $105.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$566
  • Gilead$294
  • Inari Medical, Inc.$168
  • Braeburn Inc.$130
  • AbbVie$125
  • Amarin Pharma, Inc.$123
  • plus $286 from 4 others

What the payments were for

  • Food & beverage$1,691100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,691 in reported general payments places this provider in the 75th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$22,229
Medicare patients
25
Services billed
235

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase11$23,721
FarxigaDapagliflozin Propanediol24$14,429
Oxymorphone Hcl ErOxymorphone Hcl12$14,129
Oxycodone Hcl369$9,610
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$7,567
Spiriva RespimatTiotropium Bromide11$5,289
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$4,902
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen182$2,489
Albuterol Sulfate HfaAlbuterol Sulfate69$1,679
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen91$1,350
Potassium Chloride94$958
Easy Comfort Pen NeedlePen Needle, Diabetic11$918
Alprazolam183$745
Ultra-Fine Short Pen NeedlePen Needle, Diabetic12$721
Ventolin HfaAlbuterol Sulfate13$695

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon$125$23,72111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Detroit

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →